Allkem Scheme Meeting - Chairman's address and presentation

BRISBANE, Australia, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Allkem Limited (ASX and TSX: AKE, “Allkem”) refers to the proposed merger of equals between Allkem and Livent Corporation (“Livent”), (“Transaction”).

In accordance with ASX Listing Rule 3.13, attached to this announcement are the following documents to be presented at Allkem's Scheme Meeting being held at 10:30am (AWST) / 1:30pm (AEDT) today:

• Chairman's address; and
• Scheme Meeting presentation.

Allkem shareholders may participate in the Scheme Meeting by attending in person at The Studio, Level 2, Crown Towers, Crown Perth Convention Centre, Great Eastern Highway, Burswood, Western Australia, or online at https://meetnow.global/MUHNARQ.

The voting results of the Scheme Meeting will be released to the ASX and TSX (via SEDAR+) shortly after the conclusion of the Scheme Meeting.

	Allkem Limited ABN 31 112 589 910 Level 35, 71 Eagle St Brisbane, QLD 4000	Investor Relations & Media Enquiries Andrew Barber M: [phone] E: [e-mail] Phoebe Lee P: [phone] E: [e-mail]		Connect [e-mail] [phone] www.allkem.co

IMPORTANT NOTICES

Not for release or distribution in the United States
This announcement has been prepared for publication in Australia and may not be released to U.S. wire services or distributed in the United States. This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction, and neither this announcement or anything attached to this announcement shall form the basis of any contract or commitment. Any securities described in this announcement have not been, and will not be, registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States except in transactions registered under the U.S. Securities Act of 1933 or exempt from, or not subject to, the registration of the U.S. Securities Act of 1933 and applicable U.S. state securities laws.